Multicenter Retrospective Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients

Trial Information
Status: Recruiting
Location: See location...
Study Type: Observational
Summary

Invasive filamentous fungal infections (aspergillosis, scedosporiosis, mucormycosis, fusarium wilt) are frequent and serious in immunocompromised individuals and especially in organ transplant patients. There is little recent data in liver transplantation, especially on the incidence and risk factors of fungal infections

Am I eligible for this trial?
Participation Requirements
Sex:
All
Minimum Age:
18
Healthy Volunteers:
No

• Age ≥18 years old

• Subject with liver transplantation in one of the centers participating in the study

• Invasive fungal infection with filamentous fungus between 2007-2021

• Proven or probable infection with filamentous fungi according to the EORTC / MSGERC criteria

• Subject not having expressed, after information, his opposition to the reuse of his data for scientific research purposes.

Where is this trial taking place?
Other Locations
France
Service des Maladies Infectieuses et Tropicales - Hôpitaux Universitaires de Strasbourg
Recruiting
Strasbourg
Who do I contact about this trial?
Primary
François DANION, MD
francois.danion@chru-strasbourg.fr
33 3 69 55 15 88
Backup
Saïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr
When is this trial taking place?
Start Date: November 1, 2021
Estimated Completion Date: October 29, 2023
How many participants will be in this trial?
Target number of participants: 300
What other conditions are being studied in this trial?
Liver Transplant
Mucormycosis

This content was sourced from clinicaltrials.gov